Hongbo Lu, a director at $ARWR, sold 2,970 shares of the company on 05-12-2026 for an estimated $228,333. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.4% of their shares of this class of stock. Following this trade, they now own 52,012 shares of this class of $ARWR stock.
$ARWR Insider Trading Activity
$ARWR insiders have traded $ARWR stock on the open market 50 times in the past 6 months. Of those trades, 0 have been purchases and 50 have been sales.
Here’s a breakdown of recent trading of $ARWR stock by insiders over the last 6 months:
- CHRISTOPHER RICHARD ANZALONE (Chief Executive Officer) has made 0 purchases and 13 sales selling 175,944 shares for an estimated $11,661,762.
- JAMES C HAMILTON (Chief Medical Officer) has made 0 purchases and 9 sales selling 60,164 shares for an estimated $3,926,561.
- PATRICK O'BRIEN (COO) has made 0 purchases and 12 sales selling 49,493 shares for an estimated $3,123,349.
- MAURO FERRARI has made 0 purchases and 2 sales selling 16,280 shares for an estimated $1,020,512.
- MICHAEL S PERRY sold 16,250 shares for an estimated $991,737
- DANIEL JOSEPH APEL (Chief Financial Officer) has made 0 purchases and 3 sales selling 13,095 shares for an estimated $934,285.
- VICTORIA VAKIENER has made 0 purchases and 3 sales selling 10,040 shares for an estimated $679,491.
- ADEOYE Y OLUKOTUN has made 0 purchases and 3 sales selling 10,000 shares for an estimated $676,623.
- WILLIAM D. WADDILL has made 0 purchases and 3 sales selling 8,367 shares for an estimated $566,038.
- HONGBO LU sold 2,970 shares for an estimated $228,333
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$ARWR Hedge Fund Activity
We have seen 251 institutional investors add shares of $ARWR stock to their portfolio, and 177 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 3,157,063 shares (-14.8%) from their portfolio in Q1 2026, for an estimated $197,947,850
- SLATE PATH CAPITAL LP removed 2,458,500 shares (-49.3%) from their portfolio in Q4 2025, for an estimated $163,219,815
- FRED ALGER MANAGEMENT, LLC added 1,526,164 shares (+497.4%) to their portfolio in Q4 2025, for an estimated $101,322,027
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 1,500,828 shares (-71.9%) from their portfolio in Q1 2026, for an estimated $94,101,915
- MARSHALL WACE, LLP removed 1,312,985 shares (-91.4%) from their portfolio in Q4 2025, for an estimated $87,169,074
- RENAISSANCE TECHNOLOGIES LLC added 1,036,495 shares (+inf%) to their portfolio in Q1 2026, for an estimated $64,988,236
- VESTAL POINT CAPITAL, LP added 900,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $59,751,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$ARWR Analyst Ratings
Wall Street analysts have issued reports on $ARWR in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 12/17/2025
- Chardan Capital issued a "Buy" rating on 12/01/2025
- B of A Securities issued a "Buy" rating on 12/01/2025
- RBC Capital issued a "Outperform" rating on 11/19/2025
To track analyst ratings and price targets for $ARWR, check out Quiver Quantitative's $ARWR forecast page.
$ARWR Price Targets
Multiple analysts have issued price targets for $ARWR recently. We have seen 10 analysts offer price targets for $ARWR in the last 6 months, with a median target of $87.5.
Here are some recent targets:
- William Pickering from Bernstein set a target price of $46.0 on 05/13/2026
- Luca Issi from RBC Capital set a target price of $87.0 on 05/08/2026
- Brian Cheng from JP Morgan set a target price of $88.0 on 05/01/2026
- Michael Ulz from Morgan Stanley set a target price of $100.0 on 04/21/2026
- Patrick R. Trucchio from HC Wainwright & Co. set a target price of $100.0 on 03/25/2026
- Madison El-Saadi from B. Riley Securities set a target price of $101.0 on 01/22/2026
- Edward Tenthoff from Piper Sandler set a target price of $110.0 on 01/13/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
